OTHER
Therapeutics
Review: limited evidence that adding a second antipsychotic improves clozapine treatment in schizophrenia
| The first 150 words of the full text of this article appear below. |
What is the effect of adding antipsychotics to clozapine in people with schizophrenia? Does absence of double blindness exaggerate estimates of treatment effect?
Standardised mean difference of group mean changes in the Positive and Negative Symptoms Scale or the Brief Psychiatric Rating Scale score, either from baseline to endpoint or at the end of the trial; treatment failure, defined as the proportion of people with no clinically significant response in global state.
Systematic review with meta-analysis.
Cochrane Schizophrenia Group Trials Register, MEDLINE and EMBASE were searched from inception to November 2007 for randomised controlled trials (RCTs). Reference lists of identified studies were hand searched.
Two reviewers appraised studies and selected RCTs comparing clozapine plus placebo or clozapine alone with clozapine plus another antipsychotic in adults (aged 18 years and over) with a diagnosis of schizophrenia or related disorders. There were no language restrictions. Participants had psychotic symptoms that had
National Psychosis Unit, Bethlem Royal Hospital, South London and Maudsley NHS Foundation Trust, London, UK
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
